Sponsored Research
Yongmei Liu of Cardiology has received a sub-award () through the Wake Forest University for a project entitled "Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD." Total funding will be $229,773.
Sudarshan Rajagopal of Cardiology has received an award from the American Heart Association for a project entitled "Regulation of Adrenomedullin Signaling by RAMPs in Chronic Thromboembolic Pulmonary Hypertension." Total funding will be $300,000.
Ching Zhu of Cardiology has received an award from the American Heart Association for a project entitled "The Role of Semaphorin-3a in Arrhythmogenic Nerve Remodeling after Myocardial Infarction." Total funding will be $231,000.
Mitchell Horwitz of Cell Therapy has received an award (2UG1-HL069274-24) from the National Institutes of Health for a project entitled "Blood and Marrow Transplant Clinical Trials Network." Total funding will be $1,199,830.
Ranee Chatterjee Montgomery of General Internal Medicine has received a sub-award (5U01-DK137533-02) through the Vanderbilt University Medical Center for a project entitled "CODA: COvid and Diabetes Assessment." Total funding will be $1.
Ryan Kane of General Internal Medicine has received an award from the Ardmore Institute of Health for a project entitled "Food Is Medicine Shared Medical Appointment for Weight Management: Pilot Randomized Controlled Trial." Total funding will be $77,149.
Jessica Smokoski of General Internal Medicine has received an award from the Durham Children's Initiative for a project entitled "Transforming pediatric well-child visits to strengthen early relational health: Effect and Scaling of Pediatrics Supporting Parents (PSP)." Total funding will be $40,000.
Maria Marquine of Geriatrics has received an award from the Michael J. Fox Foundation for Parkinson's Research for a project entitled "Disparities in Neurocognitive Impairment among Hispanics/Latinos in the US with Parkinson's Disease: The Role of Cardiovascular Risk." Total funding will be $133,323.
John Strouse of Hematology has received an award from the ASH Registry Inc d/b/a ASH Research Collaborative for a project entitled "Environmental Modifiers of Severity in Children with Sickle Cell Anemia (EMS-SCA)." Total funding will be $35,000.
John Perfect of Infectious Diseases has received a sub-award (5R01-AI165466-03) through the University of Toronto for a project entitled "Targeting Hsp90 in cryptococcal fungal pathogenesis." Total funding will be $241,500.
Carey Anders of Oncology has received a sub-award () through the Johns Hopkins University for a project entitled "Translational Breast Cancer Research Consortium 2024 Infrastructure - SGK." Total funding will be $35,000.
Carey Anders of Oncology has received a sub-award () through the Johns Hopkins University for a project entitled "Translational Breast Cancer Research Consortium 2024 Infrastructure (BCRF)." Total funding will be $35,000.
Rebecca Sadun of Rheumatology has received an award from the Rheumatology Research Foundation for a project entitled "Medical and Graduate Student Preceptorship: Improving Clinical Outcomes and Reducing Health System Costs through Managed Transition from Pediatric to Adult Care for Complex Rheumatic Diseases." Total funding will be $1,000.
Industry Sponsored Clinical Trials
Robert Harrison of Cardiology has received an award from Datascope Corporation for a project entitled "IABP Diastolic Augmentation Association with Patient Mortality." Total funding will be $19,999.
Adrian Hernandez of Cardiology has received an award from Bayer Aktiengesellschaft (same as Bayer AG) for a project entitled "Precision Health Alliance Membership." Total funding will be $50,000.
Renato Lopes of Cardiology has received an award from Pfizer, Inc. for a project entitled "PFIZ - Secondary Manuscripts_ARTESiA - Industry." Total funding will be $100,000.
Sudarshan Rajagopal of Cardiology has received an award from Pulmovant, Inc. for a project entitled "RVT-2301-201 - A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease." Total funding will be $389,072.
Nishant Shah of Cardiology has received an award from Alnylam Pharmaceuticals for a project entitled "A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Adult Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care." Total funding will be $210,976.
Mitchell Horwitz of Cell Therapy has received an award from Allogene Therapeutics, Inc. for a project entitled "A randomized, open-label study evaluating the efficacy and safety of cemacabtagene ansegedleucel in participants with minimal residual disease after response to first line therapy for large B-cell lymphoma (ALPHA3)." Total funding will be $602,285.
Yubin Kang of Cell Therapy has received an award from Stitching European Myeloma Network for a project entitled "A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Ciltacabtagene Autoleucel versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant." Total funding will be $1,126,728.
Jonathan Campbell of Endocrinology has received an award from Structure Therapeutics Inc. for a project entitled "Structure Therapeutics - Incretin small molecules." Total funding will be $213,007.
Jonathan Campbell of Endocrinology has received an award from Prostasis, LLC for a project entitled "Effects of NutraMeta during and following GLP-1R-mediated weight loss." Total funding will be $26,929.
Amreen Dinani of Gastroenterology has received an award from Akero Therapeutics, Inc for a project entitled "Akero AK-US-001-0105_Pro00115651 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF EFRUXIFERMIN IN SUBJECTS WITH NASH/MASH and FIBROSIS.." Total funding will be $311,615.
Amreen Dinani of Gastroenterology has received an award from 89bio, Inc for a project entitled "BIO89-100-131 The ENLIGHTEN-Fibrosis Study Pro00115755. A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis.." Total funding will be $137,741.
Christina Wyatt of Nephrology has received an award from CSL Behring LLC for a project entitled "CSL Safety CV Learning Lab." Total funding will be $121,955.
Andrew Armstrong of Oncology has received an award from Clarity Pharmaceuticals Pty Ltd (Clarity Pharmaceuticals) for a project entitled "COMBAT: A Phase I/IIa theranostic study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for identification and treatment of GRPR-expressing metastatic castrate resistant prostate cancer in patients who are ineligible for therapy with ¿¿¿Lu-PSMA-617." Total funding will be $487,088.
Jeffrey Clarke of Oncology has received an award from Adaptimmune LLC for a project entitled "A Phase 2, Open-Label, Randomized, Non-Comparative Clinical Trial of ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in Subjects With Recurrent Ovarian Cancers (SURPASS-3 STUDY/ GOG-3084)." Total funding will be $808,733.
April Salama of Oncology has received an award from Replimune, Inc. for a project entitled "Replimune RP2-202: A Randomized, Phase 2/3, Open-Label Study to Investigate the Efficacy and Safety of RP2 in Combination with Nivolumab versus Ipilimumab in Combination with Nivolumab in Immune Checkpoint Inhibitor-Naive Adult Patients with Inoperab." Total funding will be $828,581.
Hope Uronis of Oncology has received an award from AbbVie Inc. for a project entitled "[M24-977] A Phase 2 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of ABBV-400 in Combination with Fluorouracil, Leucovorin, and Budigalimab as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic Gas." Total funding will be $691,024.